Cancer-targeting nanoparticles are moving closer to human trials
SMRTR summary
MIT researchers have developed a faster, more efficient method to produce nanoparticles for targeted cancer treatment. The new microfluidic mixing technique allows for rapid layering of polymers and drugs, eliminating time-consuming purification steps and enabling production of 15 milligrams of nanoparticles in minutes instead of hours. This advancement brings the promising cancer-fighting technology closer to human clinical trials and potential commercialization.
SMRTR provides this summary for quick context. The original article belongs to MIT Technology Review.
Read the original article